It's an honor to be a part of this process to, as a basic scientist, be able to play a small role in improving the lives of ...

The Italian neuromodulation startup Newronika has secured a European approval for its closed-loop, adaptive implant for ...

Newronika, a leader in neuromodulation and adaptive deep brain stimulation (DBS) technology, announced today that it has received CE Mark approval for its AlphaDBS device, a next-generation ...

Penn State Health Milton S. Hershey Medical Center is Pennsylvania's first hospital to offer BrainSense adaptive deep brain stimulation for Parkinson’s Disease.

Newronika announced today that it received CE mark approval for its AlphaDBS device for treating Parkinson's disease.

After a twitching pinky finger led to a diagnosis of young-onset Parkinson's disease, Keith Krehbiel, then 42, stopped at a ...

Newronika has secured CE Mark approval for its AlphaDBS device aimed at the treatment of Parkinson's disease (PD), in Europe.

Generalized epilepsy has traditionally been considered a seizure of the "'whole brain.'" However, new research has challenged ...

The Parkinson's Foundation says that nearly one million people in the United States live with the disease, and around 90,000 ...

Explore lifestyle changes that may slow Parkinson's progression and enhance well-being through exercise, diet, sleep, and ...